COMPASS BIOTECHNOLOGIES, INC. Inactive Instrument
Compass Biotechnologies, Inc. Share Price Other OTC
Equities
US20452Q1031
Pharmaceuticals
| Sales 2018 | - | Sales 2019 | - | Capitalization | 158K 13.14M |
|---|---|---|---|---|---|
| Net income 2018 | - 0 | Net income 2019 | - 0 | EV / Sales 2018 | - |
| Net Debt 2018 | 516K 43.02M | Net Debt 2019 | 480K 40.05M | EV / Sales 2019 | - |
| P/E ratio 2018 |
-2.59
x | P/E ratio 2019 |
-3.95
x | Employees | - |
| Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18/20/18 |
Mathew Knowles
SAM | Sales & Marketing | - | 22/19/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Nicole Birch
CEO | Chief Executive Officer | - | 18/20/18 |
Bangi Inc. is focused on the acquisition, ownership and management of properties leased to experienced, state-licensed operators for regulated use of Cannabis facilities. The Company intends to acquire properties through sale-leaseback transactions and third-party purchases.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +35.04% | 5.92B | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| -7.89% | 1.68B | |
| +0.09% | 1.65B | |
| -12.97% | 1.53B |
